[Immediate and late results of combined treatment of dilatated cardiomyopathy in children].
Effects of combined treatment of chronic heart failure on the clinical course and outcome of dilatated cardiomyopathy was evaluated in 151 children followed up for 6 months-14 years (4.0 +/- 0.5 yr). It was shown that the use of ACE inhibitors and beta-adrenoblockers in combined therapy of this pathology improved survival and quality of life of the children
Basargina
E N
EN
Belova
N R
NR
D000293:Adolescent; D000638:Amiodarone / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005260:Female; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007223:Infant; D008297:Male; D012720:Severity of Illness Index; D014665:Vasodilator Agents / Q000627:therapeutic use
D014665:Vasodilator Agents; D000638:Amiodarone